Gilead Sciences Inc/ US3755581036 /
2024-08-30 3:10:58 PM | Chg. - | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
71.52EUR | - | 7 Turnover: 500.64 |
-Bid Size: - | -Ask Size: - | 89.39 bill.EUR | - | - |
Assets
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,100.3000 | 1,166.2000 | 1,674 | 2,276 | 2,865 | ||||||
Intangible Assets | 11,736.4000 | 11,900.1000 | 11,073 | 10,247 | 8,971 | ||||||
Long-Term Investments | 719.8000 | 439 | 1,598 | 11,601 | 20,485 | ||||||
Fixed Assets | - | - | 16,950 | 27,076 | 36,532 | ||||||
Inventories | 1,745 | 2,055.8000 | 1,386 | 1,955 | 1,587 | ||||||
Accounts Receivable | 1,751.4000 | 2,100.3000 | 4,635 | 5,854 | 4,514 | ||||||
Cash and Cash Equivalents | 1,803.7000 | 2,112.8000 | 10,027 | 12,851 | 8,229 | ||||||
Current Assets | 6,156.3000 | 7,273.8000 | 17,714 | 24,763 | 20,445 | ||||||
Total Assets | 21,239.8000 | 22,496.8000 | 34,664 | 51,839 | 56,977 |
Liabilities
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,327.3000 | 1,255.9000 | 955 | 1,178 | 1,206 | ||||||
Long-term debt | - | - | 11,921 | 21,195 | 26,346 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 13.4000 | 94.2000 | 156 | - | - | ||||||
Liabilities | 11,688.9000 | 10,752.3000 | 18,845 | 32,726 | 37,614 | ||||||
Share Capital | .8000 | 1.5340 | 2 | 1 | 1 | ||||||
Total Equity | 9,309.7000 | 11,369.1000 | 15,819 | 19,113 | 19,363 | ||||||
Minority Interests | 241.1000 | 375.4000 | 393 | 579 | 476 | ||||||
Total liabilities equity | 21,239.8000 | 22,496.8000 | 34,664 | 51,839 | 56,977 |
Income Statement
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 9,702.5000 | 11,201.7000 | 24,890 | 32,639 | 30,390 | ||||||
Depreciation (total) | - | - | 125 | 161 | - | ||||||
Operating Result | 4,010.2000 | 4,524 | 15,265 | 22,193 | 17,633 | ||||||
Interest Income | -360.9000 | -306.9000 | -412 | -688 | -964 | ||||||
Income Before Taxes | 3,612 | 4,208.2000 | 14,856 | 21,659 | 17,097 | ||||||
Income Taxes | 1,038.4000 | 1,150.9000 | 2,797 | 3,553 | 3,609 | ||||||
Minority Interests Profit | 18 | 17.5000 | 42 | -2 | -13 | ||||||
Net Income | 2,591.6000 | 3,074.8000 | 12,101 | 18,108 | 13,501 |
Per Share
Cash Flow
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,194.7000 | 3,105 | 12,818 | 20,329 | 16,669 | ||||||
Cash Flow from Investing Activities | -11,846.1000 | -254.4000 | -1,823 | -12,475 | -11,985 | ||||||
Cash Flow from Financing | 563.3000 | -2,543.9000 | -3,025 | -4,963 | -9,347 | ||||||
Decrease / Increase in Cash | -8,080.1000 | 309.1000 | 7,914 | 2,824 | -4,622 | ||||||
Employees | 5,000 | 6,100 | 7,000 | 8,000 | 9,000 |